FDA
-
-
-
-
-
-
-
Hims & Hers Expands Benefits for Active Subscribers With Eight New Health and Wellness Partners
-
-
-
-
-
-
-
Amazon One Medical launches weight management program with GLP-1 drugs
-
-
-
-
-
-
-
HIMS to offer Wegovy and Ozempic through partnership with Novo Nordisk
-
-
-
-
-
-
-
FDA issues 30 warning letters to telehealth firms over GLP-1 claims
-
-
-
-
-
-
-
Hims & Hers Health to acquire Australia's Eucalyptus for up to $1.15 billion
-
-
-
-
-
-
-
Novo Nordisk sues Hims & Hers over compounded semaglutide products
-
-
-
-
-
-
-
FDA moves to restrict copycat GLP-1 weight loss drugs
-
325,855 total articles have been posted to this entity.
Click Here to Sign-Up for StreetInsider.com Premium to View All

